Anthropic announced Claude Design, an experimental product that uses Claude to generate visuals including prototypes, slides, and one-pagers. The tool targets founders and product managers without design expertise.
Claude Design represents Anthropic's expansion into visual creation tools. The experimental product integrates Claude's capabilities to generate design assets, allowing users to quickly produce presentation materials and product mockups through text prompts.
The tool addresses a specific workflow gap: non-designers need to communicate ideas visually but lack the skills or time to create polished designs manually. By automating visual generation, Claude Design aims to reduce friction in the ideation and pitch phases.
Intended users include startup founders, product managers, and other professionals who need to share concepts quickly. The product handles common design needs like prototype sketches, presentation slides, and single-page documents—materials typically used in early-stage product development and investor pitches.
AnthropicLaunched as an experimental offering, Claude Design builds on the company's broader push into multimodal AI capabilities. The product joins Claude's existing text and image analysis features, positioning the AI assistant as a more comprehensive creative tool.
The move reflects growing competition in AI-assisted design. Other platforms have introduced similar capabilities to help non-designers generate visual content, though Anthropic's integration with Claude offers a different approach focused on conversational workflows.
As an experimental product, Claude Design's feature set and availability may evolve. Anthropic typically uses experimental launches to gather user feedback and refine tools before broader rollouts.
The announcement comes as Anthropic continues expanding Claude's applications beyond core chat functionality, including recent work in code generation, analysis, and content creation. Claude Design fits this pattern of extending the model's utility across different user needs and workflows.
Open-weight AI companies—those releasing freely available models—are attracting major acquisition interest from tech giants. The trend reflects growing capital investment in the business model of distributing AI models at no cost.
Google Deepmind has upgraded its Co-Scientist AI system to autonomously plan experiments, operate lab equipment, and publish scientific papers. The Gemini-based multi-agent platform demonstrated experimentally validated results across materials science, chemistry, and medical AI development.
Uber's weekly AI agent requests have grown nearly tenfold since February, yet the company has held spending flat since April after exhausting its entire 2026 AI budget in Q1.
A recent paper shows artificial intelligence often diagnoses and treats patients better than human physicians. The findings are prompting difficult conversations within the medical community about the profession's evolving role.